Portfolio intelligence for authorised representatives
An authorised representative managing several manufacturers rarely struggles with one registration. The hard part is keeping evidence, transition questions and open dependencies visible across every client at once.
ClinicOps adds an evidence and prioritisation layer that sits beside your existing representation and registration services.
What the partner layer does
- puts every portfolio intake into one review shape;
- separates manufacturer, AR, importer and system/procedure-pack context;
- surfaces missing or contradictory evidence before review begins;
- organises transition and document-operation questions into a work queue;
- hands off in Markdown and machine-readable JSON where that helps;
- keeps human regulatory judgement explicit.
What it does not do
ClinicOps does not replace the authorised representative relationship, a notified body or the manufacturer's RA/QA function. It removes repeated manual reconciliation and makes portfolio-scale evidence easier to review, hand off and revisit.
White-label / partner use
It works as a one-off portfolio pilot, white-label evidence reconciliation, a recurring transition work-plan update, or a structured handoff into your consultancy or AR workflow. Client-specific regulatory conclusions stay human-reviewed, inside the responsible party's process.
Pilot shape
Send one portfolio export. You get back intake diagnostics, role-aware segmentation, a prioritised work queue, an evidence-gap ledger and a human-review handoff.